309 related articles for article (PubMed ID: 10984197)
21. Therapy for the syndromes of GH excess.
Arosio M; Cannavò S; Epaminonda P; Ronchi C; Chiodini I; Adda G
J Endocrinol Invest; 2003; 26(10 Suppl):36-43. PubMed ID: 15497658
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological management of acromegaly: a current perspective.
Manjila S; Wu OC; Khan FR; Khan MM; Arafah BM; Selman WR
Neurosurg Focus; 2010 Oct; 29(4):E14. PubMed ID: 20887124
[TBL] [Abstract][Full Text] [Related]
23. [Acromegaly: multifaceted clinical presentation of a rare disease of the elderly. Report of two cases with long-term follow-up].
Foppiani L; Del Monte P; Ruelle A; Marugo A; Bernasconi D
Recenti Prog Med; 2006 Apr; 97(4):200-4. PubMed ID: 16729489
[TBL] [Abstract][Full Text] [Related]
24. [Current diagnosis and treatment of acromegaly].
Melgar V; Espinosa E; Cuenca D; Valle V; Mercado M
Rev Med Inst Mex Seguro Soc; 2015; 53(1):74-83. PubMed ID: 25680646
[TBL] [Abstract][Full Text] [Related]
25. [Akromegaly and pharmacotherapy].
Šiprová H; Souček M
Vnitr Lek; 2015 Feb; 61(2):157-60. PubMed ID: 25813261
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of pituitary gland hyperfunction: from acromegaly to prolactinoma].
Schäffler A
Internist (Berl); 2006 Dec; 47(12):1215-6, 1218-20, 1222. PubMed ID: 17033781
[TBL] [Abstract][Full Text] [Related]
27. The pathogenesis of acromegaly. Clinical and immunocytochemical analysis in 75 patients.
Laws ER; Scheithauer BW; Carpenter S; Randall RV; Abboud CF
J Neurosurg; 1985 Jul; 63(1):35-8. PubMed ID: 4009272
[TBL] [Abstract][Full Text] [Related]
28. An audit of treatment outcome in acromegalic patients attending our center at Bergamo, Italy.
Attanasio R; Montini M; Valota M; Cortesi L; Barbò R; Biroli F; Tonnarelli G; Albizzi M; Testa RM; Pagani G
Pituitary; 2008; 11(1):1-11. PubMed ID: 17690987
[TBL] [Abstract][Full Text] [Related]
29. Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
Karavitaki N; Turner HE; Adams CB; Cudlip S; Byrne JV; Fazal-Sanderson V; Rowlers S; Trainer PJ; Wass JA
Clin Endocrinol (Oxf); 2008 Jun; 68(6):970-5. PubMed ID: 18031313
[TBL] [Abstract][Full Text] [Related]
30. Combination treatment with somatostatin analogues and pegvisomant in acromegaly.
Neggers SJ; van der Lely AJ
Growth Horm IGF Res; 2011 Jun; 21(3):129-33. PubMed ID: 21498099
[TBL] [Abstract][Full Text] [Related]
31. [The OASIS study: therapeutic management of acromegaly in standard clinical practice. Assessment of the efficacy of various treatment strategies].
Luque-Ramírez M; Carreño A; Alvarez Escolá C; del Pozo Picó C; Varela da Costa C; Fajardo Montañana C; Gilabert M; Webb S;
Endocrinol Nutr; 2011 Nov; 58(9):478-86. PubMed ID: 22032858
[TBL] [Abstract][Full Text] [Related]
32. [The treatment of acromegaly].
Beauregard H; Somma M; Rasio E; Serri O; Aris-Jilwan N; Comtois R; Long H; Abribat T; Boucher A; Hardy J
Union Med Can; 1993; 122(6):489-95. PubMed ID: 8303792
[TBL] [Abstract][Full Text] [Related]
33. Evidence for dopamine agonists in the treatment of acromegaly.
Jaquet P
J Endocrinol; 1997 Oct; 155 Suppl 1():S59-60. PubMed ID: 9389998
[No Abstract] [Full Text] [Related]
34. [Role of somatostatin receptor ligands in the treatment of acromegaly--literature review].
Nemes O; Mezosi E
Orv Hetil; 2011 May; 152(18):715-21. PubMed ID: 21498160
[TBL] [Abstract][Full Text] [Related]
35. Current treatment guidelines for acromegaly.
Melmed S; Jackson I; Kleinberg D; Klibanski A
J Clin Endocrinol Metab; 1998 Aug; 83(8):2646-52. PubMed ID: 9709926
[TBL] [Abstract][Full Text] [Related]
36. Drug insight: Primary medical therapy of acromegaly.
Katznelson L
Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):109-17; quiz following 117. PubMed ID: 16932265
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic management of acromegaly].
Metzner C; Hadziselimovic S; Grafe I; Nawroth P; Kasperk C
Med Klin (Munich); 2006 Jan; 101(1):15-23. PubMed ID: 16418810
[TBL] [Abstract][Full Text] [Related]
38. New formulations and approaches in the medical treatment of acromegaly.
Debono M; Newell-Price J
Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):350-5. PubMed ID: 20502324
[TBL] [Abstract][Full Text] [Related]
39. [Growth hormone receptor antagonist in the treatment of acromegaly].
Hubina E; Tóth A; Kovács GL; Dénes J; Kovács L; Góth M
Orv Hetil; 2011 May; 152(18):709-14. PubMed ID: 21498159
[TBL] [Abstract][Full Text] [Related]
40. Evolving therapeutic strategies for acromegaly.
Darzy KH; Shalet SM
J Endocrinol Invest; 2001 Jun; 24(6):468-71. PubMed ID: 11434673
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
